Effect of high-frequency chest wall oscillation on pulmonary function after pulmonary lobectomy for non-small cell lung cancer.

Park, Heesung; Park, JoonSuk; Woo, Sook Young; Yi, Young Hee; Kim, Kwhanmien
Critical care medicine
2012Sep ; 40 ( 9 ) :2583-9.
저자 상세정보
Park, Heesung -
Park, JoonSuk -
Woo, Sook Young -
Yi, Young Hee -
Kim, Kwhanmien -
ABSTRACT
OBJECTIVE: We examined the feasibility of high-frequency chest wall oscillationtherapy in immediate postoperative lung recruitment after pulmonary lobectomy for non-small cell lung cancer compared to conventional chest physiotherapy. DESIGN: A prospective, single-blind, randomized trial was conducted at Samsung Medical Center between March 2010 and May 2010. SETTING: Patients were randomized to either the high-frequency chest wall oscillation group or the conventional percussive physiotherapy (control) group. PATIENTS: : Briefly, the eligibility criteria included 1) participants between the ages of 35 and 70 yrs, 2) candidates of lobectomy for non-small cell lung cancer, and 3) the first elective surgery of the day. Sixty-six patients were enrolled in the study. INTERVENTIONS: Patients in the control group had routine postoperative percussive chest physiotherapy four times a day. Participants in the high-frequency chest wall oscillation group received three sessions of high-frequency chest wall oscillation treatment every 8 hrs for 15 mins starting 4 hrs after surgery. All the treatments and measurements were performed by randomly assigned nursing staff who had received standardized education for respiratory care and who were not aware of the details of the study. MEASUREMENTS AND MAIN

RESULTS: The primary outcome was postoperative change of forced expiratory volume for 1 sec, and secondary outcomes were changes in arterial oxygen partial pressure and saturation. Safety outcomes and pain scores were also investigated. Patients in the high-frequency chest wall oscillation group experienced significantly improved recovery of pulmonary function as assessed by forced expiratory volume for 1 sec on the third and fifth postoperative days (p = .03) and improved oxygenation on the first postoperative day (p < .01). There were no significant differences in pain score or analgesic requirements. There were no unexpected complications, such as hemodynamic deterioration, postoperative bleeding or chest tube, and wound problems associated with the high-frequency chest wall oscillation therapy.

CONCLUSIONS: High-frequency chest wall oscillation therapy after pulmonary lobectomy resulted in significantly improved immediate postoperative pulmonary function recovery compared to conventional physiotherapy, without any significant adverse effects. These results suggest that high-frequency chest wall oscillation therapy may be a valuable tool in the postoperative care of non-small cell lung cancer patients with lobectomy.
Chest physiotherapy; high-frequency chest wall oscillation; lobectomy; lung recruitment therapy; non-small cell lung cancer; pulmonary function
MESH
Adult, Aged, Carcinoma, Non-Small-Cell Lung/pathology/surgery/*therapy, Chest Wall Oscillation/*methods, Female, Follow-Up Studies, Forced Expiratory Flow Rates, Humans, Korea, Lung Neoplasms/pathology/surgery/*therapy, Male, Middle Aged, Oxygen Consumption/*physiology, Pneumonectomy/*methods, Postoperative Care/methods, Prospective Studies, Pulmonary Gas Exchange, Reference Values, Respiratory Function Tests, Respiratory Therapy/methods, Risk Assessment, Single-Blind Method, Treatment Outcome
링크

주제코드
주제명(Target field)
연구대상(Population)
연구참여(Sample size)
대상성별(Gender)
질병특성(Condition Category)
연구환경(Setting)
연구설계(Study Design)
연구기간(Period)
중재방법(Intervention Type)
중재명칭(Intervention Name)
키워드(Keyword)
유효성결과(Recomendation)
HFCWO therapy in patients who have undergone lobectomy for NSCLC significantly improved pulmonary function and arterial oxygenation in the immediate postoperative period compared to conventional chest physiotherapy.
연구비지원(Fund Source)
근거수준평가(Evidence Hierarchy)
출판년도(Year)
참여저자수(Authors)
대표저자
DOI
10.1097/CCM.0b013e318258fd6d.
KCD코드
ICD 03
건강보험코드